Evidence map›Paper›PMID 28352677›Full record

ReviewOpen medicine (Warsaw, Poland)2015

Amlodipine as an antiischemic drug is superior to long acting nitrates.

Goran P Koraćević, Sonja S Dakić, Radmila M Veličković-Radovanović, Svetlana R Apostolović, Nebojša H Krstić, Ivan S Tasić, Marija D Zdravković, Nebojša M Antonijević, Goran N Damnjanović, Tomislav L Kostić

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Open medicine (Warsaw, Poland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Goran P KoraćevićDepartment for Cardiovascular Diseases, Clinical center Niš, Bulevar Dr Z. Djindjića 48, 18000 Niš, Serbia, Medical Faculty, University of Niš, Bulevar Dr Zorana Djindjića 81, 18 000 Niš, Serbia.
Sonja S DakićDepartment for Cardiovascular Diseases, Clinical center Niš, Bulevar Dr Z. Djindjića 48, 18000 Niš, Serbia.
Radmila M Veličković-RadovanovićMedical Faculty, University of Niš, Bulevar Dr Zorana Djindjića 81, 18 000 Niš, Serbia Department of Clinical Pharmacology, Clinical center Niš, Bulevar Dr Zorana Djindjića 48, 18 000 Serbia.
Svetlana R ApostolovićDepartment for Cardiovascular Diseases, Clinical center Niš, Bulevar Dr Z. Djindjića 48, 18000 Niš, Serbia, Medical Faculty, University of Niš, Bulevar Dr Zorana Djindjića 81, 18 000 Niš, Serbia.
Nebojša H KrstićDepartment for Cardiovascular Diseases, Clinical center Niš, Bulevar Dr Z. Djindjića 48, 18000 Niš, Serbia.
Ivan S TasićDepartment for Cardiovascular Diseases, Clinical center Niš, Bulevar Dr Z. Djindjića 48, 18000 Niš, Serbia Institute for therapy and prevention Niška Banja, Srpskih junaka 2, 18 205 Niška Banja, Serbia.
Marija D ZdravkovićClinical Hospital Center Bežanijska kosa, Faculty of Medicine, Univesirty of Belgrade, Bežanijska kosa bb, 11 000 Belgrade, Serbia.
Nebojša M AntonijevićSchool of Medicine, Belgrade, Clinic of Cardiology, Clinical Centre of Serbia, Pasterova 2, 11 000 Belgrade, Serbia.
Goran N DamnjanovićMilitary Hospital Niš, Bulevar Dr Zorana Đinđića bb, 18 000 Niš, Serbia.
Tomislav L KostićDepartment for Cardiovascular Diseases, Clinical center Niš, Bulevar Dr Z. Djindjića 48, 18000 Niš, Serbia.
University of Nis · RSUniversity Hospital Medical Center Bezanijska kosa · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

European Society of Cardiology Guidelines cite results of meta-analysis that the use of calcium channel blockers results in fewer angina episodes per week vs. long-acting nitrates. Moreover, we listed 12 reasons more to prefer amlodipine over long-acting nitrates, especially in stable angina pectoris patients with arterial hypertension. It may be the way to decrease polypharmacy without loosing efficacy. Some important advantages of amlodipine versus long-acting nitrate(s) are: amlodipine also treats hypertension, it helps reducing hypertensive target organ damages (e.g. left ventricular hypertrophy) and prevents morning blood pressure surge. Moreover, amlodipine can be given once daily (which improves adherence), it produces neither tolerance nor rebound, it has less side effects.

Indexed as

AmlodipineLong acting nitratesStable angina pectoris

Identifiers

PMID28352677
PMCPMC5152957
OpenAlexW1984573265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.